Association of anemia with the risk of cardiovascular adverse events in overweight/obese patients

International Journal of Obesity

Volumn 38, Issue 3, 2014, Pages 432-437

  Winther, S A ^a   Finer, N ^b   Sharma, A M ^c   Torp Pedersen, C ^d   Andersson, C ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ALBERTA   (Canada)

^d AALBORG UNIVERSITY   (Denmark)

Author keywords

anemia; cardiovascular death; cardiovascular disease; epidemiology

Indexed keywords

PLACEBO; SIBUTRAMINE; ANOREXIGENIC AGENT; CYCLOBUTANE DERIVATIVE;

ADULT; AGED; ANEMIA; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART ARREST; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OBESITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; INFLAMMATION; KIDNEY FAILURE; METABOLISM; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ANEMIA; APPETITE DEPRESSANTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CYCLOBUTANES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RISK FACTORS;

EID: 84896316961     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2013.111     Document Type: Article

References (36)

1. Riva E, Tettamanti M, Mosconi P, Apolone G, Gandini F, Nobili A et al. Association of mild anemia with hospitalization and mortality in the elderly: The Health and Anemia population-based study. Haematologica 2009; 94: 22-28
2. Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves PH, Newman AB et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: The Cardiovascular Health Study. Arch Intern Med 2005; 165: 2214-2220
3. Culleton BF, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Hemmelgarn BR. Impact of anemia on hospitalization and mortality in older adults. Blood 2006; 107: 3841-3846
4. Dong X, Mendes De LC, Artz A, Tang Y, Shah R, Evans D. A population-based study of hemoglobin, race, and mortality in elderly persons. J Gerontol A Biol Sci Med Sci 2008; 63: 873-878
5. Penninx BW, Pahor M, Woodman RC, Guralnik JM. Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci 2006; 61: 474-479
6. Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 2002; 40: 27-33
7. Tsujita K, Nikolsky E, Lansky AJ, Dangas G, Fahy M, Brodie BR et al. Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). Am J Cardiol 2010; 105: 1385-1394
8. Anand IS. Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 2008; 52: 501-511
9. Del FP, Luthi JC, Carrera E, Michel P, Burnier M, Burnand B. Anemia and chronic kidney disease are potential risk factors for mortality in stroke patients: A historic cohort study. BMC Nephrol 2010; 11: 27
10. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497
11. Cepeda-Lopez AC, Aeberli I, Zimmermann MB. Does obesity increase risk for iron deficiency? A review of the literature and the potential mechanisms. Int J Vitam Nutr Res 2010; 80: 263-270
12. McClung JP, Karl JP. Iron deficiency and obesity: The contribution of inflammation and diminished iron absorption. Nutr Rev 2009; 67: 100-104
13. Zimmermann MB, Zeder C, Muthayya S, Winichagoon P, Chaouki N, Aeberli I et al. Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification. Int J Obes 2008; 32: 1098-1104
14. Lecube A, Carrera A, Losada E, Hernandez C, Simo R, Mesa J. Iron deficiency in obese postmenopausal women. Obesity 2006; 14: 1724-1730
15. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M. Overweight children and adolescents: A risk group for iron deficiency. Pediatrics 2004; 114: 104-108
16. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: Risk factor paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53: 1925-1932
17. James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 2010; 363: 905-917
18. Verhave JC, Fesler P, Ribstein J, du CG, Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: Influence of age and body mass index. Am J Kidney Dis 2005; 46: 233-241
19. Meneveau N, Schiele F, Seronde MF, Descotes-Genon V, Oettinger J, Chopard R et al. Anemia for risk assessment of patients with acute coronary syndromes. Am J Cardiol 2009; 103: 442-447
20. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111: 2042-2049
21. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003; 107: 223-225
22. Charlot M, Torp-Pedersen C, Valeur N, Seibaek M, Weeke P, Kober L. Anaemia and long term mortality in heart failure patients: A retrospective study. Open Cardiovasc Med J 2010; 4: 173-177
23. Tanne D, Molshatzki N, Merzeliak O, Tsabari R, Toashi M, Schwammenthal Y. Anemia status, hemoglobin concentration and outcome after acute stroke: A cohort study. BMC Neurol 2010; 10: 22
24. Levy PS, Quigley RL, Gould SA. Acute dilutional anemia and critical left anterior descending coronary artery stenosis impairs end organ oxygen delivery. J Trauma 1996; 41: 416-423
25. Most AS, Ruocco Jr. NA, Gewirtz H. Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. Circulation 1986; 74: 1085-1092
26. Muzzarelli S, Pfisterer M. Anemia as independent predictor of major events in elderly patients with chronic angina. Am Heart J 2006; 152: 991-996
27. Ausk KJ, Ioannou GN. Is obesity associated with anemia of chronic diseasé A population-based study. Obesity (Silver Spring) 2008; 16: 2356-2361
28. Menzie CM, Yanoff LB, Denkinger BI, McHugh T, Sebring NG, Calis KA et al. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc 2008; 108: 145-148
29. Cepeda-Lopez AC, Osendarp SJ, Melse-Boonstra A, Aeberli I, Gonzalez-Salazar F Feskens E et al. Sharply higher rates of iron deficiency in obese Mexican women and children are predicted by obesity-related inflammation rather than by differences in dietary iron intake. Am J Clin Nutr 2011; 93: 975-983
30. Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006; 131: 788-796
31. Tussing-Humphreys LM, Nemeth E, Fantuzzi G, Freels S, Holterman AX, Galvani C et al. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery. Obesity 2010; 18 2010-6
32. Lipsic E, van Der Meer P, van Veldhuisen DJ. Erythropoiesis-stimulating agents and heart failure. Cardiovasc Ther 2011; 29: E52-e59
33. Kotecha D, Ngo K, Walters JA, Manzano L, Palazzuoli A, Flather MD. Erythropoietin as a treatment of anemia in heart failure: Systematic review of randomized trials. Am Heart J 2011; 161: 822-831
34. McMurray JJ, Anand IS, Diaz R, Maggioni AP, O?Connor C, Pfeffer MA et al. Design of the reduction of events with Darbepoetin alfa in heart failure (RED-HF): A Phase III, anaemia correction, morbidity-mortality trial. Eur J Heart Fail 2009; 11: 795-801
35. Singh AK. Diabetes, anemia and CKD: Why TREAT? Curr Diab Rep 2010; 10: 291-296
36. Skali H, Parving HH, Parfrey PS, Burdmann EA, Lewis EF, Ivanovich P et al. Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: The trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation 2011; 124: 2903-2908